INS and type 2 diabetes mellitus: In the Dubbo Osteoporosis Epidemiology Study (DOES), type 2 diabetes (median type 2 diabetes duration of 6.3 years, 17% requiring insulin therapy) was not associated with increased fracture risk at any site over a median of 13 years of follow-up [15].